Suvankar Banerjee

19PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 29, 2025
PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies.

Ambati Himaja, Debojyoti Halder, Suvankar Banerjee

|Sep 26, 2025
Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis.

Suvankar Banerjee, Sandip Kumar Baidya, Tarun Jha

|Nov 26, 2024
Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors.

Goverdhan Lanka, Suvankar Banerjee, Sanjeev Regula

|Aug 28, 2024
Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis.

S K Baidya, S Banerjee, B Ghosh

|Aug 09, 2024
A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present).

Suvankar Banerjee, Balaram Ghosh, Tarun Jha

|May 17, 2024
Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors.

T Jha, R Jana, S Banerjee

Pageof 4

Frequent Collaborators

19 joint publications

Nilanjan Adhikari

17 joint publications

Tarun Jha

14 joint publications

Balaram Ghosh

12 joint publications

Sandip Kumar Baidya